|
|
|
|
|
|
|
|
|
Immunetics Profile I mmunetics’ mission is to develop and bring to market products which solve significant problems in diagnostic testing and research today, based on the best technology available. As a Company, we have pursued this mission since 1987. Our accomplishments include the development of patented instruments such as the Miniblotter® for Western Blot, spoligotyping, and other multi-probe membrane assays, a Cell Adhesion Flow Chamber for microarray hybridization, the QualiCode™ line of Western Blot assays for diseases where diagnosis is exceptionally challenging, and recently, the FDA-approved C6 B. burgdorferi (Lyme) ELISA™ Kit, setting a new performance standard in Lyme testing. All of our products are available directly from Immunetics in the U.S. and through a network of distributors internationally. Immunetics has received numerous SBIR grants for development of assays and instrumentation, and our products are referenced in numerous scientific publications. We collaborate with researchers worldwide to transform cutting edge technology into new products for clinical diagnostics and research applications.
Immunetics, Inc. |